Since the definition of MAFLD involves hepatic steatosis, overweight/obesity, metabolic dysregulation, and diabetes, it may be reasonable to speculate that increased circulating levels of adipsin are associated with MAFLD. The gene discussed is CFD; the disease is obesity disorder.